The PIPR quantified with the 6 s metric has been shown to be effective in detecting melanopsin dysfunction in glaucoma [13,18,55,56], age-related macular degeneration [14] and ischemic optic neuropathy [15] in humans. This evidence concerns the gene OPN4 and glaucoma.